Moxolunic LP Eye Drop is a combination ophthalmic solution containing Loteprednol etabonate (0.5% w/v), a corticosteroid, and Moxifloxacin (0.5% w/v), a broad-spectrum antibiotic. This synergistic formulation is designed to effectively manage inflammatory and bacterial eye conditions, offering relief from discomfort while addressing underlying infections.
Loteprednol etabonate reduces inflammation, redness, swelling, and itching in the eyes by inhibiting the body's inflammatory response. Its targeted action minimizes the risk of systemic side effects commonly associated with corticosteroids. Moxifloxacin, a fluoroquinolone antibiotic, eliminates bacteria by interfering with their DNA synthesis, ensuring quick and effective treatment of bacterial infections.
Moxolunic LP Eye Drop is indicated for post-operative inflammation, bacterial conjunctivitis, and other conditions requiring combined anti-inflammatory and antimicrobial therapy. It provides dual benefits: controlling infection and reducing associated inflammation, ensuring faster recovery and enhanced comfort.
The formulation is well-tolerated and delivers precise dosing, making it suitable for adult and pediatric use under medical supervision. It offers a convenient and effective solution for maintaining eye health and preventing complications arising from bacterial infections or inflammation.